A history of anaphylaxis with interferon therapy A history of severe depression or suicidal ideation A history of epilepsy not adequately controlled by therapy Decompensated liver disease (cirrhosis or severe hepatic disease, or visible jaundice) Chronic kidney disease with a known or suspected creatinine clearance <30 ml/min. For women: pregnant, or breastfeeding, or is considering becoming pregnant during the study. Currently taking interferon for other indications. Patient is, in the opinion of the investigator, unable to accurately record their pulse oximetry readings. Participation in a COVID-19 clinical study involving an investigational agent within the preceding 30 days. The participant is considered

A history of anaphylaxis with interferon therapy A history of severe depression or suicidal ideation A history of epilepsy not adequately controlled by therapy Decompensated liver disease (cirrhosis or severe hepatic disease, or visible jaundice) Chronic kidney disease with a known or suspected creatinine clearance <30 ml/min. For women: pregnant, or breastfeeding, or is considering becoming pregnant during the study. Currently taking interferon for other indications. Patient is, in the opinion of the investigator, unable to accurately record their pulse oximetry readings. Participation in a COVID-19 clinical study involving an investigational agent within the preceding 30 days. The participant is considered